
Recurrent depression and anxiety can be resistant to monotherapies, including psychotherapy, eye movement desensitization and reprocessing (EMDR), and selective serotonin reuptake inhibitors (SSRIs). Over a 12-week tPBM protocol, participants reported improvements in sleep quality, irritability, and depression scores, though anxiety outcomes varied across measures. These preliminary findings suggest that tPBM may offer supportive benefits alongside conventional treatments.
Read the publicationPartners
Neuronic Corporation
King's College London


